developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; SAR-bisPSMA, a theranostic ...

ASX 200 healthcare share Clarity Pharmaceuticals Ltd (ASX: CU6) is the worst performer of the S&P/ASX 200 Index (ASX: XJO) on Tuesday.

64 Cu-SAR-Bombesin PET-CT imaging in the staging of ER+/PR+/HER2- metastatic breast cancer: Safety, dosimetry, and feasibility in a phase I trial.

Ranatensin 是一种从两栖动物（如青蛙 Rana pipiens）皮肤中分离的十一肽，属于蛙皮素受体（Bombesin Receptor）的激动剂。以下是其核心特性与研究价值的概述： 基本特征 结构：由11个氨基酸组成的直链多肽，具有两栖动物皮肤分泌肽的典型特征。 来源：主要从蛙类 ...

Meanwhile, the company's three lead products SAR-bisPSMA, SAR-Bombesin and SARTATE are actively progressing through eight clinical trials, comprising three theranostic trials and five diagnostic ...

Peptide-drug conjugates (PDCs) represent an emerging class of targeted therapeutic agents that consist of small molecular drugs coupled to multifunctional peptides through cleavable or non-cleavable ...

In May 2023, a novel tracer, flotufolastat F 18 (POSLUMA®), formerly referred to as 18 F-rhPSMA-7.3, was approved by the FDA as a PSMA-PET tracer for the staging of prostate cancer patients with a ...